Posted Jun. 21, 2017 at 9:23 a.m.

Premium Lock Eshelman, Hatteras backed Innocrin lands regulatory boost in Europe

Published: 2017-06-21 09:23:50
Updated: 2017-06-21 09:23:50

Innocrin Innocrin

​Durham-based Innocrin Pharmaceuticals, a clinical-stage company focused on developing new cancer treatments, has received a regulatory boost for its work in Europe....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders